| Literature DB >> 27208331 |
Eric Renard1, Anne Farret2, Jort Kropff3, Daniela Bruttomesso4, Mirko Messori5, Jerome Place2, Roberto Visentin6, Roberta Calore6, Chiara Toffanin5, Federico Di Palma5, Giordano Lanzola7, Paolo Magni7, Federico Boscari4, Silvia Galasso4, Angelo Avogaro4, Patrick Keith-Hynes8, Boris Kovatchev8, Simone Del Favero6, Claudio Cobelli6, Lalo Magni5, J Hans DeVries3.
Abstract
OBJECTIVE: After testing of a wearable artificial pancreas (AP) during evening and night (E/N-AP) under free-living conditions in patients with type 1 diabetes (T1D), we investigated AP during day and night (D/N-AP) for 1 month. RESEARCH DESIGN AND METHODS: Twenty adult patients with T1D who completed a previous randomized crossover study comparing 2-month E/N-AP versus 2-month sensor augmented pump (SAP) volunteered for 1-month D/N-AP nonrandomized extension. AP was executed by a model predictive control algorithm run by a modified smartphone wirelessly connected to a continuous glucose monitor (CGM) and insulin pump. CGM data were analyzed by intention-to-treat with percentage time-in-target (3.9-10 mmol/L) over 24 h as the primary end point.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27208331 DOI: 10.2337/dc16-0008
Source DB: PubMed Journal: Diabetes Care ISSN: 0149-5992 Impact factor: 19.112